Ronald E. Osman - 01 Apr 2024 Form 4 Insider Report for Inhibitor Therapeutics, Inc. (INTI)

Role
Director, 10%+ Owner
Signature
/s/ Ronald E. Osman
Issuer symbol
INTI
Transactions as of
01 Apr 2024
Net transactions value
$0
Form type
4
Filing time
16 May 2024, 13:34:32 UTC
Previous filing
29 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INTI Common Stock Award $0 +50,000 +0.21% $0.000000 23,564,985 01 Apr 2024 Seefootnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2014 Equity Incentive Plan.
F2 These shares represent 100,000 shares owned by Mr. Osman and remaining number of shares of common stock held by The Ronald E. Osman Trust III. Mr. Osman is the sole trustee of the Ronald E. Osman Trust III.